Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q20706932> ?p ?o }
Showing triples 1 to 35 of
35
with 100 triples per page.
- Q20706932 subject Q7145142.
- Q20706932 subject Q7215860.
- Q20706932 subject Q8479056.
- Q20706932 subject Q8918235.
- Q20706932 abstract "Mirogabalin (DS-5565) is a drug developed by Daiichi Sankyo and related to drugs such as gabapentin and pregabalin. Similarly to these drugs, mirogabalin binds to the α2δ calcium channels (1 and 2), but with significantly higher potency than pregabalin. It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain, and is currently in Phase III trials.".
- Q20706932 casNumber "1138245-21-2".
- Q20706932 iupacName "(1R,5S,6S)-6-(aminomethyl)-3-ethyl-bicyclo(3.2.0)hept-3-ene-6-acetic acid".
- Q20706932 pubchem "49802951".
- Q20706932 thumbnail Mirogabalin.svg?width=300.
- Q20706932 wikiPageWikiLink Q17854930.
- Q20706932 wikiPageWikiLink Q18033947.
- Q20706932 wikiPageWikiLink Q246819.
- Q20706932 wikiPageWikiLink Q30612.
- Q20706932 wikiPageWikiLink Q410352.
- Q20706932 wikiPageWikiLink Q412174.
- Q20706932 wikiPageWikiLink Q4198677.
- Q20706932 wikiPageWikiLink Q4812635.
- Q20706932 wikiPageWikiLink Q669441.
- Q20706932 wikiPageWikiLink Q7118738.
- Q20706932 wikiPageWikiLink Q7145142.
- Q20706932 wikiPageWikiLink Q7215860.
- Q20706932 wikiPageWikiLink Q7825858.
- Q20706932 wikiPageWikiLink Q8479056.
- Q20706932 wikiPageWikiLink Q8918235.
- Q20706932 casNumber "1138245".
- Q20706932 iupacName "-6".
- Q20706932 pubchem "49802951".
- Q20706932 type ChemicalSubstance.
- Q20706932 type Drug.
- Q20706932 type ChemicalObject.
- Q20706932 type Thing.
- Q20706932 type Q8386.
- Q20706932 comment "Mirogabalin (DS-5565) is a drug developed by Daiichi Sankyo and related to drugs such as gabapentin and pregabalin. Similarly to these drugs, mirogabalin binds to the α2δ calcium channels (1 and 2), but with significantly higher potency than pregabalin. It has shown promising results in Phase II clinical trials for the treatment of diabetic peripheral neuropathic pain, and is currently in Phase III trials.".
- Q20706932 label "Mirogabalin".
- Q20706932 depiction Mirogabalin.svg.